Clinical trial
Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer
NCT03298763 is registered in ClinicalTrials.gov with University College, London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer
- Lead sponsor
- University College, London
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- March 5, 2019
- Completion date
- September 1, 2025
- Enrollment
- 46 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.